Project Grant K99CA304505
Award Date 8/12/25
Completion Date 7/31/27
Dollars Obligated $181K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
- The National Cancer Institute (NCI), under the Cancer Research Manpower Federal Grant Program (CFDA 93.398), awarded a $165,271 Project Grant to Emory University for the "Training to Prevent Anal Cancer (TPAC)" program. The TPAC program aims to develop, pilot, and evaluate an educational curriculum to train women's health, infectious disease, and colorectal providers to conduct anal cancer screening among high-risk individuals, such as solid organ transplant recipients and women with a...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to The Medical College of Wisconsin, Inc. (MCW) totaling $1,270,070 will fund a 5-year randomized controlled trial called the "Self-Sampling to Optimize Anal Lesion Outcomes (SOLO)" study. The study aims to assess whether home-based self-sampling and in-clinic self-sampling for anal cancer screening can increase attendance at follow-up cytology and high-resolution anoscopy...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to the Medical University of South Carolina provides $629,179 to optimize treatment for human papillomavirus-associated oropharyngeal cancer in older adults. The 5-year project aims to: 1) characterize the impact of aging and multimorbidity on treatment outcomes and patient preferences, 2) develop and validate a microsimulation model to compare harms vs. benefits of different...
- The National Cancer Institute (NCI) awarded a 5-year, $753,446 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Boston Medical Center Corporation (BMC) to adapt and test an intervention to improve cervical cancer screening and follow-up in three diverse, underserved populations. The intervention combines education and quality improvement methods using performance improvement continuing medical education. It aims to decrease the overall burden of cervical...
- The National Cancer Institute (NCI) awarded a $168,500 Project Grant under the "Cancer Cause and Prevention Research" (CFDA 93.393) program to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The two-year grant, with an ultimate completion date of July 31, 2025, aims to evaluate physical and mental health symptoms (patient-reported outcomes) throughout the cancer diagnosis trajectory and their associations with cancer outcomes among HIV-positive...
- This Project Grant award of $442,750 was provided by the National Cancer Institute (NCI) under the federal Cancer Cause and Prevention Research program (CFDA 93.393). The award supports a study led by researchers at New York University (NYU) to identify determinants of successful policy implementation for cervical cancer control in low- and middle-income countries in Africa, as well as potential strategies to strengthen such policy implementation. The research will involve a Delphi process to...
- This federal Project Grant award of $2,991,283.00 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support research to characterize patterns of low-dose computed tomography (LDCT)-based lung cancer screening among people with and without HIV in the United States. The project aims to leverage the OneFlorida+ electronic health record database covering over 21 million patients to analyze LDCT screening trends, follow-up, and outcomes in this population....
- The National Cancer Institute (NCI) awarded a $825,966 Project Grant to the University of Texas MD Anderson Cancer Center under the Cancer Cause and Prevention Research (CFDA 93.393) federal grant program. The grant, which has an award date of September 4, 2025 and an ultimate completion date of August 31, 2030, will fund a randomized controlled trial to test the effects of a multilevel, culturally adapted storytelling intervention. The intervention aims to address stigma at both the patient and...
- The federal Project Grant award of $637,596 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) is for a research project titled "Interventions to Decrease Cancer Information Avoidance". The goal is to develop and test a video-based intervention designed to reduce defensive avoidance of colorectal cancer information and increase engagement, in order to improve screening rates among those who typically avoid such information (about 20% of the...
- The U.S. National Cancer Institute (NCI) has awarded a $851,463 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant, effective September 1, 2025 through August 31, 2030, aims to leverage big data analytics and electronic health record (EHR) data from the OneFlorida+ Clinical Research Network to characterize the impacts of HIV and cancer stigma on cancer care...